• 2005

Company Description

Avexxin's therapeutic approach is built on more than a decade of research into the biological mechanisms involved in inflammatory diseases

Avexxin's therapeutic approach is built on more than a decade of research into the biological mechanisms involved in inflammatory diseases at the Norwegian University of Science and Technology. Avexxin's goal is to create a therapeutic company based on the discovery and development of novel therapeutics that address the fundamental mechanisms involved in inflammatory diseases.

  • Manufacturer:

    Science and Engineering
  • Formed:

    2005
  • Company Website:

  • Company E-mail:

  • Company Address:

    Department of Biology, Norwegian University of Science and Technology, Høgskoleringen 5
    Trondheim
    Norway
  • CEO:

    • Mikael Ørum
  • We recognize our sponsors starting at $1 per entry.
    Learn more at https://www.ithistory.org/benefits